Key R&D programs moving biotech stocks

TheSteet's Adam Feuerstein takes at look today at some of the most actively traded biotech stocks today, highlighting a number of companies such as AVEO Pharmaceuticals ($AVEO), Targacept ($TRGT) and Vertex Pharmaceuticals ($VRTX). These developers are awaiting key clinical data that are expected to boost of sink some of the companies' stocks. If nothing else, it's a good primer for several important drug R&D programs in the biotech industry. Item

Suggested Articles

Less than two years after taking the reins from founding chief Rusty Williams, Five Prime Therapeutics’ CEO Aron Knickerbocker is exiting the company.

A Roche compound that was designed to treat rheumatoid arthritis could improve the heart's ability to repair itself, a Vanderbilt team found.

After a whirlwind year and two quick-fire raises, cancer startup Black Diamond Therapeutics has nabbed Yumanity, Merck KGaA and SR One veterans to help head up…